FNAM

Evolutionary Genomics, Inc. [FNAM] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

FNAM Stock Summary

Top 10 Correlated Stocks

FNAM

In the News

FNAM Financial details

Company Rating
-
Market Cap
2.99M
Income
-254.77K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
09 Mar 2024
P/E
-3.31
Forward P/E
-
PEG
0.36
P/S
-
P/B
-0.47
P/C
-
P/FCF
-9.34
Quick Ratio
3.68
Current Ratio
3.92
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-36.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.83%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-34%
ROE
15%
ROC
-0.44%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.45-0.72
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
416
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
0%
-
-
-
-
Beta
-0.357
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0008
Change
0%

Something similar

Top by Market Cap
DHR-PB
3V64.DE
0YXG.L
CMC.DE
FB2A.DE
Same Sector
002868.SZ
OCPNF
KYMR
CTEC.L
SNY
Top Correlated Stocks
TCCO
GHSI
OGN.L
AKOM
AMCT
Similar Market Cap
SGGFF
ATNF
IFNY
GULTU
RVLP

Company Profile

Healthcare Biotechnology
  • Volume Average 416
  • Market Capitalization 2.99M
  • Employee 2
  • CEO Mr. Steve B. Warnecke
  • Headquarters Castle Rock,CO,US
  • IPO Date 2012-05-15
  • Website https://www.evolgen.com

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.